Aurinia Pharmaceuticals (NasdaqGM:AUPH) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Speaker6Good morning. Welcome to the Aurinia Pharmaceuticals fourth quarter and full year 2025 conference call. Please be advised that a Q&A session will follow Aurinia's prepared remarks. We ask you please ask 1 question and 1 follow-up, then return to the queue. I'll now turn the call over to Peter Greenleaf, President and Chief Executive Officer of Aurinia. Peter, please go ahead.Speaker7Good morning. We want to t ...